Revenue
$490.7M
▲ 110.5% YoY
Net Income
-$25.5M
▲ 92.1% YoY
EPS
$-0.29
▲ 92.9% YoY
Cash
$93.0M
▲ 58.9% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
REED ELIZABETH E Chief Legal Officer and GC | Vest | Mar 16, 2026 | 10.0K | $19.08 | $191K | Form 4 ↗ |
REED ELIZABETH E Chief Legal Officer and GC | Sell | Mar 16, 2026 | 10.0K | $28.09 | $281K | Form 4 ↗ |
Dube Eric M CHIEF EXECUTIVE OFFICER | Vest | Feb 20, 2026 | 60.0K | $15.46 | $928K | Form 4 ↗ |
Dube Eric M CHIEF EXECUTIVE OFFICER | Sell | Feb 20, 2026 | 60.0K | $30.10 | $1.81M | Form 4 ↗ |
REED ELIZABETH E Chief Legal Officer and GC | Vest | Feb 17, 2026 | 10.0K | $19.08 | $191K | Form 4 ↗ |
REED ELIZABETH E Chief Legal Officer and GC | Sell | Feb 17, 2026 | 5.7K | $27.50 | $156K | Form 4 ↗ |
REED ELIZABETH E Chief Legal Officer and GC | Sell | Feb 17, 2026 | 4.3K | $28.26 | $122K | Form 4 ↗ |
Inrig Jula CHIEF MEDICAL OFFICER | Sell | Feb 4, 2026 | 1.5K | $32.11 | $50K | Form 4 ↗ |
Inrig Jula CHIEF MEDICAL OFFICER | Sell | Feb 4, 2026 | 232 | $32.85 | $8K | Form 4 ↗ |
Cline Christopher R. CHIEF FINANCIAL OFFICER | Sell | Feb 4, 2026 | 1.6K | $32.14 | $53K | Form 4 ↗ |
Cline Christopher R. CHIEF FINANCIAL OFFICER | Sell | Feb 4, 2026 | 110 | $32.90 | $4K | Form 4 ↗ |
REED ELIZABETH E Chief Legal Officer and GC | Sell | Feb 4, 2026 | 2.5K | $32.07 | $80K | Form 4 ↗ |
REED ELIZABETH E Chief Legal Officer and GC | Sell | Feb 4, 2026 | 509 | $32.74 | $17K | Form 4 ↗ |
Dube Eric M CHIEF EXECUTIVE OFFICER | Sell | Feb 3, 2026 | 66.5K | $32.06 | $2.13M | Form 4 ↗ |
Dube Eric M CHIEF EXECUTIVE OFFICER | Sell | Feb 3, 2026 | 33.6K | $32.70 | $1.10M | Form 4 ↗ |
Inrig Jula CHIEF MEDICAL OFFICER | Sell | Feb 3, 2026 | 7.0K | $32.12 | $223K | Form 4 ↗ |
Cline Christopher R. CHIEF FINANCIAL OFFICER | Sell | Feb 3, 2026 | 7.2K | $32.12 | $233K | Form 4 ↗ |
Heerma Peter CHIEF COMMERCIAL OFFICER | Sell | Feb 3, 2026 | 7.3K | $32.12 | $235K | Form 4 ↗ |
ROTE WILLIAM E. Chief Research Officer | Sell | Feb 3, 2026 | 12.4K | $32.87 | $409K | Form 4 ↗ |
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | Sell | Feb 3, 2026 | 4.3K | $32.12 | $139K | Form 4 ↗ |
Dube Eric M CHIEF EXECUTIVE OFFICER | Grant | Jan 31, 2026 | 113.8K | $0.00 | $0 | Form 4 ↗ |
Inrig Jula CHIEF MEDICAL OFFICER | Grant | Jan 31, 2026 | 28.1K | $0.00 | $0 | Form 4 ↗ |
Cline Christopher R. CHIEF FINANCIAL OFFICER | Grant | Jan 31, 2026 | 28.1K | $0.00 | $0 | Form 4 ↗ |
Heerma Peter CHIEF COMMERCIAL OFFICER | Grant | Jan 31, 2026 | 26.1K | $0.00 | $0 | Form 4 ↗ |
ROTE WILLIAM E. Chief Research Officer | Grant | Jan 31, 2026 | 20.1K | $0.00 | $0 | Form 4 ↗ |
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | Grant | Jan 31, 2026 | 15.2K | $0.00 | $0 | Form 4 ↗ |